KALV – kalvista pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat for the Treatment of Hereditary Angioedema Plus an Equity Investment in KalVista Pharmaceuticals [Yahoo! Finance]
KalVista Pharmaceuticals Announces Pricing of a $55 Million Underwritten Offering of Common Stock and Concurrent Private Placement of $5 Million
KalVista Pharmaceuticals Enters into Non-Dilutive Synthetic Royalty Financing with DRI Healthcare Trust
Form 4 KalVista Pharmaceuticals For: Nov 17 Filed by: Palleiko Benjamin L
Form 4 KalVista Pharmaceuticals For: Nov 17 Filed by: Yea Christopher
Form 4 KalVista Pharmaceuticals For: Nov 17 Filed by: Audhya Paul K.
Form SC 13G/A KalVista Pharmaceuticals Filed by: TANG CAPITAL MANAGEMENT LLC
Form SC 13G/A KalVista Pharmaceuticals Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.